20 October 2023 -- London, UK -- FlyPharma Europe, a conference and exhibition for the pharmaceutical logistics industry, brought together industry leaders, regulators, and logistics service providers to discuss the latest innovations and best practices in pharmaceutical and life science transportation
19 October 2023
Www.mmc-series.org.uk
24 September 2023
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
24 September 2023
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
24 September 2023'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Product Profile, 24 September 2023
12 September 2023 -- Chelmsford, UK -- The FLEXPOINT dot laser modules have been engineered to meet the increasing demands of industries such as industrial manufacturing, medical technology, research and beyond.
Product Profile, 11 September 2023
22 August 2023 -- Chelmsford, UK -- After the 40th company anniversary last year, the LASER COMPONETS Group will celebrate two more decisive milestones in the company's history in 2023. LASER COMPONENTS UK, the first sales office abroad, was opened 30 years ago. Ten years later, the LASER COMPONENTS Detector Group followed in Arizona.
Product Profile, 21 August 2023
15 August 2023 -- Chelmsford, UK -- LASER COMPONENTS manufacturers laser optics and specialises in custom optical coatings from small to high volumes, using E-beam, IAD and IBS deposition methods.
Product Profile, 14 August 2023
15 August 2023 -- Chelmsford, UK -- LASER COMPONENTS, a global leader in photonics and optoelectronics, is excited to unveil the innovative VIEW-IT Infrared Laser Detector Kit, featuring the revolutionary Pocket Card and Wand Detectors. This cutting-edge kit marks a significant advancement in laser detection technology, offering professionals a comprehensive solution for accurate and efficient detection of infrared (IR) laser emissions.
Product Profile, 14 August 2023
Excitement is mounting for the upcoming London Biotechnology Show 2024, a highly anticipated event scheduled for the 8th and 9th of May at Olympia West. The buzz is palpable as we've already received over 1000 inquiries related to biotechnology, fueling anticipation and speculation about what this show will offer.
Press Releases, 6 December 2023
— X-Chem, a global leader in innovative drug discovery services, announces the achievement of a drug discovery milestone, following a partner’s attainment of a development candidate. Relay Therapeutics, a leader in cutting-edge approaches to drug discovery, utilized X-Chem’s DNA-Encoded Library (DEL) platform to perform hit finding intended to discover molecules with differentiated pharmacological properties.
Press Releases, 6 December 2023
EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader.
Press Releases, 6 December 2023
: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH) was important for confirmation of efficacy for INI-822 from Inipharm, a biopharmaceutical company focused on discovering and developing therapies for severe liver diseases.
Press Releases, 4 December 2023
The Global Bio-India 2023 event organised by the Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India, and its Public Sector Undertaking, Biotechnology Industry Research Assistance Council (BIRAC), is set to take place from 4-6 December 2023, India. Global Bio-India 2023 will be the largest congregation of biotech startups and the central theme of the conference is Biotech Innovation and Bio-manufacturing.
Press Releases, 4 December 2023
An exploration of the thoughts on the significance of generative AI within life sciences and pharma
Digital, 24 September 2023
What Pharma 4.0 looks like, the strategic role that a laboratory information management system plays and the presentation of a case study that underscores the power of a well-aligned digital strategy to catalyse innovation within organisations
Digital, 24 September 2023
IPT talks to Robert Strzelecki at TenderHut group about the development of AI in the pharma industry and how its implementation will grow the sector
Digital, 24 September 2023
Could the Cloud be the catalyst many pharma QC labs need in their race to the Lab of the Future?
Digital, 24 September 2023
As it grows more sophisticated, artificial intelligence will have transformative implications across virtually every industry on earth. One area in which this impact is already being felt is biotechnology, where it is playing a prominent role in everything from drug and vaccine development to providing global food security
Digital, 24 September 2023Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
While the drug-device combination product industry is always investing in technology that could better meet the needs of patients, governments and sponsors, the COVID-19 pandemic has accelerated the process, bringing in more outside investment and a broader range of organisations in active development
What are some trends in the mRNA space surrounding the growing desire for speed-to-market, and what hurdles are impeding the achievement of this goal?
Drug product optimisation, also known as reformulation, is a development step required by all drugs en route to market. This process takes a long time, carries a considerable cost and places significant emphasis on the predictive power of laboratory and preclinical assessments. What are some alternative pathways available to development teams?
For different binder-diluent ratios on the tablet mechanical strength, a proposed scale could serve as a ‘guiding torch’ for various formulators while designing preclinical or early phase formulations
High-titre CLD platform is an effective tool to overcome a number of challenges when developing a cell line. What are the challenges associated with developing a high-titre CLD platform and how can utilising novel technologies help overcome them?
Nanodrug carriers have gained increased attention in the pharma industry since they were used in the fight against COVID-19. What are they, and how can regulations improve the manufacture of them?
What are the differences and key design features which characterise successful tablet press performance in a continuous manufacturing setting?
IPT talks to Richard Stedman of ACG Engineering about the rise of connected and digitalised machines, and how these will improve pharmaceutical manufacturing in the future
How are current events in drug development demanding better enteric delivery solutions, and how is material science and manufacturing innovation creating a purpose-built capsule able to go the distance – all while reducing the cost and complexity of enteric development and delivery?
MUPS formulations are a widely used pharmaceutical dosage form for esomeprazole, a proton pump inhibitor. For this purpose, micropellets are coated with the active ingredient and administered in the form of tablets or capsules. An appropriate solution for the coating of micropellets is the use of fluid bed processors which utilise air flow bed technology
Since their introduction in 1956, pressurised metered dose inhalers (pMDIs) have become the dominant treatment choice for patients suffering from common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). However, unbeknown to most patients and many doctors, pMDIs account for 3.9% of NHS’s annual carbon emissions.1 Here we will discuss how formulation changes might be the answer to the pMDI-related sustainability problem
Manufacturers are deploying flexible containment in both existing and new-build manufacturing sites. Why are they choosing this over traditional rigid isolators, and what are the considerations they should take into account when doing this?
Ensuring pharma products are manufactured in a safe and controlled way is a priority. How can the industry ensure that this happens?
Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is complex, requiring developers to better understand the factors that impact regulatory classification
The adaptation of e-cigarettes as drug delivery devices holds great potential for inhalation therapy. So, can we apply the advances made in nicotine delivery to other active substances?
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations
Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades
The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
IPT talks to Oliver Rinner of Biognosys about Bruker’s recent majority investment in the business and how this, along with its own developments, will affect the future of proteomics research
Discovery and Development, 24 September 2023
With its potential to transform various industries and fields of research − including pharmaceuticals, preventive healthcare, agriculture and food safety − metabolomics is a rapidly growing field that has the potential to revolutionise our understanding of biological systems and disease mechanisms
Discovery and Development, 24 September 2023
IPT talks to Tamsin Mansley of Optibrium about how AI has been used in drug discovery up until now, and how it can be best applied in the future
Discovery and Development, 3 April 2023
Non-human cells have been used in drug discovery for years. How are novel technologies helping researchers to move past this method?
Discovery and Development, 3 April 2023
What has led to the rising trend for Cell & Gene Therapy (CGT) developers to choose retroviral vectors over other potential vectors, and what are the many drivers behind this selection process?
Discovery and Development, 14 December 2022
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
Analytics, 24 September 2023Www.mmc-series.org.uk
Analytics, 24 September 2023
The pharmaceutical industry is seeking new ways to accelerate the drug development process, to generate both time and cost savings. How is nuclear magnetic resonance spectroscopy helping to improve the drug development sector?
Analytics, 7 June 2023
Flow cytometry is a powerful technology in the emerging cell and gene therapies (CGT) field and plays a significant role in various stages in the adoptive cell therapies, but what are its advantages and limitations?
Analytics, 7 June 2023
rAAV vectorology is being optimised to allow for highly specific expression and greater efficacy – how is this being achieved, and why is it so important?
Analytics, 3 April 2023
Recent developments in gene therapy and the approval of mrna vaccines for treating diseases has seen the biopharmaceutical industry’s need for more well-characterised rna and oligonucleotides than ever before. How are more nucleic acid sequences being analysed by mass spectrometry (ms) through the development of new technologies, and how can innovations in software process data fully automate the workflow of the confirmation of oligonucleotide sequences based on intact ms/ms
Analytics, 3 April 2023
23 October 2023 -- Roslin, Scotland -- Biotech company, Cytomos is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcessUK Dragon’s Den special session focused on next generation analytical technologies, taking place on day two of this year’s annual conference: 30 November
Conferences and Events , 22 October 202320 October 2023 -- London, UK -- FlyPharma Europe, a conference and exhibition for the pharmaceutical logistics industry, brought together industry leaders, regulators, and logistics service providers to discuss the latest innovations and best practices in pharmaceutical and life science transportation
Conferences and Events , 19 October 2023
13 October 2023 -- Liverpool, UK -- This year’s scientific tracks cover a wide range of themes including ‘omics, personalised medicine and chemistry, all focused on bringing new therapies from the lab to the patient
Conferences and Events , 12 October 2023
13 October 2023 -- Munich, Germany -- BIO-Europe has grown to be recognised as Europe's flagship partnering event, and its 29th edition will take place 6-8 November 2023 in Munich, Germany
Conferences and Events , 12 October 2023
3 October 2023 -- Massachusetts, US -- – Innovator in laboratory digital transformation and leading global provider of cloud-based solutions for science, Scitara, presents its Digital Lab Exchange DLX platform as the missing link that enables laboratories to embrace true digital transformation and develop a modern composable enterprise-led IT strategy at Lab of the Future Europe 2023, 26-27 September, Amsterdam
Conferences and Events , 2 October 2023
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
